These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 24892810)
21. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. Moir S; Ho J; Malaspina A; Wang W; DiPoto AC; O'Shea MA; Roby G; Kottilil S; Arthos J; Proschan MA; Chun TW; Fauci AS J Exp Med; 2008 Aug; 205(8):1797-805. PubMed ID: 18625747 [TBL] [Abstract][Full Text] [Related]
22. Higher Genetic Diversity and Viral Evolution in Key Regions of the Envelope Gene Are Associated with Broader Neutralizing Antibody Responses: a Report of Two Chronic HIV Infected Cases. Shen S; Tian W; Ji Y; Gao Y; Zhang M; Han X; Shang H Jpn J Infect Dis; 2019 Sep; 72(5):312-317. PubMed ID: 31257237 [TBL] [Abstract][Full Text] [Related]
23. Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge. Styles TM; Gangadhara S; Reddy PBJ; Hicks S; LaBranche CC; Montefiori DC; Derdeyn CA; Kozlowski PA; Velu V; Amara RR J Virol; 2019 Oct; 93(20):. PubMed ID: 31341049 [TBL] [Abstract][Full Text] [Related]
24. Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response. Shrivastava T; Samal S; Tyagi AK; Goswami S; Kumar N; Ozorowski G; Ward AB; Chakrabarti BK Vaccine; 2018 Mar; 36(12):1627-1636. PubMed ID: 29429810 [TBL] [Abstract][Full Text] [Related]
25. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120. Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Derdeyn CA Front Immunol; 2018; 9():3163. PubMed ID: 30697215 [TBL] [Abstract][Full Text] [Related]
26. Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers. Buranapraditkun S; Pissani F; Teigler JE; Schultz BT; Alter G; Marovich M; Robb ML; Eller MA; Martin J; Deeks S; Michael NL; Streeck H J Virol; 2017 Jul; 91(14):. PubMed ID: 28468877 [TBL] [Abstract][Full Text] [Related]
27. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques. Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585 [TBL] [Abstract][Full Text] [Related]
28. Low Peripheral T Follicular Helper Cells in Perinatally HIV-Infected Children Correlate With Advancing HIV Disease. McCarty B; Mwamzuka M; Marshed F; Generoso M; Alvarez P; Ilmet T; Kravietz A; Ahmed A; Borkowsky W; Unutmaz D; Khaitan A Front Immunol; 2018; 9():1901. PubMed ID: 30197641 [TBL] [Abstract][Full Text] [Related]
29. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates. García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M J Virol; 2017 May; 91(9):. PubMed ID: 28179536 [TBL] [Abstract][Full Text] [Related]
30. Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response. Heydarchi B; Center RJ; Gonelli C; Muller B; Mackenzie C; Khoury G; Lichtfuss M; Rawlin G; Purcell DF PLoS One; 2016; 11(6):e0157353. PubMed ID: 27300145 [TBL] [Abstract][Full Text] [Related]
31. Early preservation of CXCR5+ PD-1+ helper T cells and B cell activation predict the breadth of neutralizing antibody responses in chronic HIV-1 infection. Cohen K; Altfeld M; Alter G; Stamatatos L J Virol; 2014 Nov; 88(22):13310-21. PubMed ID: 25210168 [TBL] [Abstract][Full Text] [Related]
32. Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV. Bussmann BM; Reiche S; Bieniek B; Krznaric I; Ackermann F; Jassoy C Virology; 2010 Feb; 397(1):7-13. PubMed ID: 19962720 [TBL] [Abstract][Full Text] [Related]
33. An HIV-1 envelope immunogen with W427S mutation in CD4 binding site induced more T follicular helper memory cells and reduced non-specific antibody responses. Yu HT; Tian D; Wang JY; Guo CX; Li Y; Wang X; Li D; Zhang FM; Zhuang M; Ling H PLoS One; 2014; 9(12):e115047. PubMed ID: 25546013 [TBL] [Abstract][Full Text] [Related]
34. Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremia. Medina-Ramírez M; Sánchez-Merino V; Sánchez-Palomino S; Merino-Mansilla A; Ferreira CB; Pérez I; González N; Alvarez A; Alcocer-González JM; García F; Gatell JM; Alcamí J; Yuste E J Virol; 2011 Jun; 85(12):5804-13. PubMed ID: 21471239 [TBL] [Abstract][Full Text] [Related]
35. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded. Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121 [TBL] [Abstract][Full Text] [Related]
36. Control of Viremia Enables Acquisition of Resting Memory B Cells with Age and Normalization of Activated B Cell Phenotypes in HIV-Infected Children. Muema DM; Macharia GN; Hassan AS; Mwaringa SM; Fegan GW; Berkley JA; Nduati EW; Urban BC J Immunol; 2015 Aug; 195(3):1082-91. PubMed ID: 26116511 [TBL] [Abstract][Full Text] [Related]
37. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates. Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491 [TBL] [Abstract][Full Text] [Related]
38. Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs. Ren Y; Korom M; Truong R; Chan D; Huang SH; Kovacs CC; Benko E; Safrit JT; Lee J; Garbán H; Apps R; Goldstein H; Lynch RM; Jones RB J Virol; 2018 Dec; 92(23):. PubMed ID: 30209173 [TBL] [Abstract][Full Text] [Related]
39. Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopes. Das S; Boliar S; Mitra N; Samal S; Bansal M; Koff WC; Chakrabarti BK Retrovirology; 2016 Nov; 13(1):81. PubMed ID: 27871328 [TBL] [Abstract][Full Text] [Related]
40. The development of CD4 binding site antibodies during HIV-1 infection. Lynch RM; Tran L; Louder MK; Schmidt SD; Cohen M; ; Dersimonian R; Euler Z; Gray ES; Abdool Karim S; Kirchherr J; Montefiori DC; Sibeko S; Soderberg K; Tomaras G; Yang ZY; Nabel GJ; Schuitemaker H; Morris L; Haynes BF; Mascola JR J Virol; 2012 Jul; 86(14):7588-95. PubMed ID: 22573869 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]